These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28678657)

  • 1. A significant mechanism of molecular recognition between bioflavonoids and P-glycoprotein leading to herb-drug interactions.
    Wongrattanakamon P; Nimmanpipug P; Sirithunyalug B; Chansakaow S; Jiranusornkul S
    Toxicol Mech Methods; 2018 Jan; 28(1):1-11. PubMed ID: 28678657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the molecular mechanism of P-glycoprotein mediated drug toxicity induced by bioflavonoids: an integrated computational approach.
    Wongrattanakamon P; Lee VS; Nimmanpipug P; Sirithunyalug B; Chansakaow S; Jiranusornkul S
    Toxicol Mech Methods; 2017 May; 27(4):253-271. PubMed ID: 27996361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.
    Bai J; Zhao S; Fan X; Chen Y; Zou X; Hu M; Wang B; Jin J; Wang X; Hu J; Zhang D; Li Y
    Toxicol Appl Pharmacol; 2019 Apr; 369():49-59. PubMed ID: 30790579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approach.
    Gadhe CG; Kothandan G; Cho SJ
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1636-44. PubMed ID: 23796247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulation and molecular docking studies of 1,4-Dihydropyridines as P-glycoprotein's allosteric inhibitors.
    Shahraki O; Zargari F; Edraki N; Khoshneviszadeh M; Firuzi O; Miri R
    J Biomol Struct Dyn; 2018 Jan; 36(1):112-125. PubMed ID: 27981890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: structure-activity relationships for flavonoid binding.
    de Wet H; McIntosh DB; Conseil G; Baubichon-Cortay H; Krell T; Jault JM; Daskiewicz JB; Barron D; Di Pietro A
    Biochemistry; 2001 Aug; 40(34):10382-91. PubMed ID: 11513617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of substrate/non-substrate recognition by P-glycoprotein.
    Mukhametov A; Raevsky OA
    J Mol Graph Model; 2017 Jan; 71():227-232. PubMed ID: 27984797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer.
    Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV
    Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
    J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and dynamic perspectives on the promiscuous transport activity of P-glycoprotein.
    Subramanian N; Condic-Jurkic K; O'Mara ML
    Neurochem Int; 2016 Sep; 98():146-52. PubMed ID: 27180050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative steroid-binding sites in human ABCB1 and ABCG2.
    Mares-Sámano S; Badhan R; Penny J
    Eur J Med Chem; 2009 Sep; 44(9):3601-11. PubMed ID: 19303670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
    Beaudet L; Urbatsch IL; Gros P
    Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions.
    Tran VH; Marks D; Duke RK; Bebawy M; Duke CC; Roufogalis BD
    Nutr Cancer; 2011; 63(3):435-43. PubMed ID: 21462089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structure-differential binding method for elucidating the interactions between flavonoids and cytochrome-c by ESI-MS and molecular docking.
    Wang X; Liu Y; Wang H
    Talanta; 2013 Nov; 116():368-75. PubMed ID: 24148417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
    Raj U; Kumar H; Varadwaj PK
    J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.
    Conseil G; Baubichon-Cortay H; Dayan G; Jault JM; Barron D; Di Pietro A
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9831-6. PubMed ID: 9707561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux.
    Loo TW; Clarke DM
    J Membr Biol; 2005 Aug; 206(3):173-85. PubMed ID: 16456713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics.
    Parate S; Kumar V; Hong JC; Lee KW
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.